CAAP Company: ChipCare Retains Biotech Alliances International to Lead Series B Capital Raise

OBIO News
Written By Guest User

ChipCare, a Toronto-based start-up diagnostic company, announced today that San Francisco-based life sciences investment bank Biotech Alliances International will serve as the lead investment banker for its $18.8 million Series B capital raise, $2.8 million of which has already been secured.

Full press release here

Guest User
Previous

OBIO Presents at Sunnybrook Medventions Innovation Day
Next

Call for Innovations: Canadian Centre for Aging and Brain Health Innovation (CC-ABHI)